Orgenesis Inc.
ORGSOTCHealthcare● Active
$0.50
+$0.01(+1.02%)
Market Cap$2558779
P/E Ratio—
52W High$5.89
52W Low$0.02
Orgenesis Inc. (ORGS) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ORGS · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2023-12 | 2022-12 | 2021-12 | 2020-12 | 2019-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($64.92M) | ($12.17M) | ($18.06M) | $0.58M | ($26.04M) |
| Depreciation & Amort. | $1.56M | $1.98M | $1.86M | $1.44M | $3.81M |
| Stock-Based Comp. | $0.46M | $0.98M | $1.75M | $19.89M | $5.70M |
| Change in Working Capital | $36.63M | ($19.98M) | ($15.40M) | ($3.28M) | $3.30M |
| Net Cash from Operations | ($14.84M) | ($24.92M) | ($26.87M) | ($78.05M) | ($13.22M) |
| Investing Activities | |||||
| Capital Expenditure | ($2.10M) | ($12.42M) | ($7.87M) | ($1.52M) | ($12.13M) |
| Purchases of Investments | ($0.03M) | ($0.01M) | ($0.03M) | ($0.55M) | ($1.73M) |
| Sales of Investments | $0.00M | $1.31M | $0.00M | $0.02M | ($11.55M) |
| Net Cash from Investing | ($3.71M) | ($14.13M) | ($12.38M) | $105.61M | ($13.78M) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00M | $0.00M | ($1.02M) | ($0.25M) | $0.00M |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | $3.33M | $16.80M | ($1.02M) | ($2.61M) | $10.90M |
| Net Cash from Financing | $13.62M | $39.58M | ($0.11M) | $5.88M | $24.10M |
| Free Cash Flow | |||||
| Free Cash Flow | ($16.93M) | ($37.34M) | ($34.73M) | ($79.57M) | ($25.35M) |
| FCF Margin %(computed) | — | -103.65% | -97.83% | — | -76.22% |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · M
Explore more Orgenesis Inc. data
About Orgenesis Inc. (ORGS) Cash Flow Statement
Orgenesis Inc. generated operating cash flow of ($0.01B) and free cash flow of ($0.02B) for 2023 — a FCF margin of -3194.91%. Capital expenditure was ($0.00B).
Frequently asked questions
ORGS · 4 questionsOrgenesis Inc. generated free cash flow of ($0.02B) for 2023, up 54.7% year-over-year.
ORGS free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10